ArticleFrontiers in immunology2023

Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study.

Xingying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.